Urology Surgical Instruments Market Report 2026

Urology Surgical Instruments Market Overview

• Urology Surgical Instruments market size has reached to $14.14 billion in 2025 • Expected to grow to $22.66 billion in 2030 at a compound annual growth rate (CAGR) of 10.1% • Growth Driver: Increasing Prevalence Of Urologic Conditions Driving Growth In The Urology Surgical Instruments Market • Market Trend: Innovative Advances In Urology Surgical Instruments: Focus On Advanced Robotic Surgery Devices • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Urology Surgical Instruments Market?

Urology surgical instruments refer to specialized equipment that urologists use to identify and treat diseases of the male reproductive system and urinary tract. These instruments are designed to be precise, durable and easy to use during the procedures. The main types of urology surgical instruments products are urology endoscopes, endovision systems, peripheral systems, urology consumables and accessories and others. A urology endoscope is a tool with a light attached that is used to view the urethra, bladder and ureter or renal pelvis and calyces (ureterorenoscopy) respectively. The disease types are kidney diseases, pelvic organ prolapse, urological cancer and BPH and others used in hospitals and clinics, dialysis centers and others

What Is The Urology Surgical Instruments Market Growth Forecast?

The urology surgical instruments market size is expected to see rapid growth in the next few years. It will grow to $22.66 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for advanced urology surgical instruments in minimally invasive surgeries, growing procedural load in dialysis and specialty centers, rising adoption of specialized peripheral and diagnostic urology systems, expansion of oncology driven urological interventions, increasing instrument upgrades to improve precision and surgical efficiency. Major trends in the forecast period include increasing demand for minimally invasive and precision-based urology surgical procedures, rising utilization of durable and ergonomically designed urology surgical instruments for complex interventions, growing preference for specialized instruments for kidney disease and urological cancer surgeries, expanding procedural volume in hospitals and clinics driving higher instrument replacement cycles, increasing adoption of reusable and procedure-specific consumables in urology operating environments.

Global Urology Surgical Instruments Market Segmentation

1) By Product Type: Urology Endoscopes, Endovision Systems, Peripheral Systems, Urology Consumables And Accessories, Other Product Types 2) By Disease Type: Kidney Diseases, Pelvic Organ Prolapse, Urological Cancer And BPH, Other Diseases 3) By End User: Hospitals And Clinics, Dialysis Centers, Other End Users Subsegments: 1) By Urology Endoscopes: Rigid Endoscopes, Flexible Endoscopes 2) By Endovision Systems: Imaging Systems, Visualization Systems 3) By Peripheral Systems: Urology Surgical Instruments, Urology Diagnostic Instruments 4) By Urology Consumables and Accessories: Biopsy Forceps, Scissors, Electrodes 5) By Other Product Types: Catheters, Guidewires, Other Specialized Instruments

What Is The Driver Of The Urology Surgical Instruments Market?

The rising incidence of urologic conditions is expected to propel the growth of the urology surgical instruments market. Urologic conditions describe various conditions impacting the male or female reproductive or urinary tract systems. Some of the most prevalent urologic diseases are kidney stones, urinary tract infections, bladder control and prostate issues. The urologist uses urology surgical instruments to properly diagnose and treat urological conditions by performing various procedures. For instance, in November 2024, according to the Prostate Cancer Research, a UK-based non-profit organization, prostate cancer is the second leading cause of cancer-related deaths in men after lung cancer, and its incidence in the UK is expected to rise by 15% between 2023–2025 and again in 2038–2040. Therefore, the rising incidence of urologic conditions drives the urology surgical instruments industry.

Key Players In The Global Urology Surgical Instruments Market

Major companies operating in the urology surgical instruments market are Medtronic Plc, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., CooperSurgical Inc., Coloplast A/S, Teleflex Incorporated, Cook Medical LLC, Karl Storz SE & CO. KG, Integer Holdings Corporation, Conmed Corporation, Richard Wolf GmbH, Dornier Medtech GmbH, HealthTronics Inc., Surgical Holdings Inc., Sklar Surgical Instruments Corporation, Millennium Surgical Corporation

Global Urology Surgical Instruments Market Trends and Insights

Major companies operating in the urology surgical instruments market are focused on developing new innovative products, such as advanced robotic surgery devices, to strengthen their market position. Advanced surgery devices are innovative and specialized tools and equipment for minimally invasive surgery, surgical robotics and other advanced surgical procedures. For instance, in March 2023, University Hospital (UH), a US-based academic medical center and the principal teaching hospital, launched single-port robotic surgery to treat urologic cancer and other urological conditions. Single-port robotic urologic cancer surgery is an extension of laparoscopic surgery, performed through small incisions in the abdomen. The single-port surgery takes this a step further by allowing surgical equipment to be accessed through a single, two-inch incision. Intuitive's cutting-edge robotic technology enables surgical instruments to enter the body together before traveling to their required placements within the abdominal cavity.

What Are Latest Mergers And Acquisitions In The Urology Surgical Instruments Market?

In January 2024, Boston Scientific Corporation, a US-based medical technology company, acquired Axonics, Inc. for $3.7 billion. Through this acquisition, Boston Scientific aims to expand its urology portfolio with differentiated technologies to treat urinary and bowel dysfunction and strengthen its ability to serve urologists treating patients with chronic conditions. Axonics, Inc. is a US-based medical technology company focused on the development and commercialization of devices to treat urinary and bowel dysfunction, including sacral neuromodulation systems and urethral bulking systems for female stress urinary incontinence.

Regional Outlook

North America was the largest region in the urology surgical instruments market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Urology Surgical Instruments Market?

The urology surgical instruments market consists of sales of instruments, consumables, dialysis machines, endovision devices, laser systems and imaging devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.